Robert Nelsen - Director, 10%+ Owner at Prime Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
PRME on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Nelsen since 11/27/2024

Holdings reported by Robert Nelsen for Prime Medicine, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.23M $7.91M $1.27 Aug 1, 2025 By ARCH Venture Fund XII, L.P.
Common Stock 6.13M $7.78M $1.27 Aug 1, 2025 By ARCH Venture Fund X, L.P.
Common Stock 6.13M $7.78M $1.27 Aug 1, 2025 By ARCH Venture Fund X Overage, L.P.
Common Stock 16.1K $20.4K $1.27 Aug 1, 2025 Indirect
Stock Option (right to buy) 45K Aug 1, 2025 Direct Common Stock

Transactions reported by Robert Nelsen for Prime Medicine, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.